Skip to main content

5 Result(s)

within Julien Rossignol Remove this filter Oncology Remove this filter

and

  1. No Access

    Article

    Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee

    Systemic Mastocytosis (SM) is a multifaceted clinically heterogeneous disease. Advanced SM (AdvSM) comprises three entities: aggressive SM (ASM), mast cell leukaemia (MCL) and SM with an associated hematologic...

    Donal P. McLornan, Tomasz Czerw, Gandhi Damaj, Mark Ethell, Carmelo Gurnari… in Leukemia (2024)

  2. No Access

    Article

    Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases

    Systemic inflammatory and autoimmune diseases (SIADs) occur in 10–20% of patients with myelodysplastic syndrome (MDS). Recently identified VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndr...

    Vincent Jachiet, Laure Ricard, Pierre Hirsch… in Clinical and Experimental Medicine (2023)

  3. No Access

    Article

    Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis

    In the current classification of the World Health Organization (WHO), bone marrow mastocytosis (BMM) is a provisional variant of indolent systemic mastocytosis (ISM) defined by bone marrow involvement and abse...

    Roberta Zanotti, Massimiliano Bonifacio, Giuseppe Lucchini, Wolfgang R. Sperr… in Leukemia (2022)

  4. No Access

    Article

    Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry

    Systemic mastocytosis (SM) is frequently associated with eosinophilia. To examine its prevalence and clinical impact in all WHO classification-based subcategories, we analyzed eosinophil counts in 2350 mastocy...

    Hanneke C. Kluin-Nelemans, Andreas Reiter, Anja Illerhaus, Bjorn van Anrooij… in Leukemia (2020)

  5. No Access

    Article

    High concentration of topical amitriptyline for treating chemotherapy-induced neuropathies

    Chemotherapy-induced peripheral neuropathy (CIPN) is a devastating pain condition of cancer therapy that may force chemotherapy dose reduction or discontinuation. Since treatment options for CIPN are quite lim...

    Julien Rossignol, Benoit Cozzi, François Liebaert… in Supportive Care in Cancer (2019)